2017 ACR/ARHP Annual Meeting

November 3-8, 2017. San Diego, CA.

View by Number View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Abstract Number: 644

Association of Osteonectin, Osteopontin and Osteocalcin with Inflammation and Cardiovascular Risk in Patients with Axial Spondyloarthritis
Abstract Number: 1454

Association of Poor Prognostic Factors with Medication Persistence Among Adult RA Patients within a Community of Rheumatology Clinics
Abstract Number: 2122

Association of Retroperitoneal Fibrosis with Malignancy
Abstract Number: 2591

Association of Smoking and Cutaneous Manifestations in Systemic Lupus Erythematosus (SLE): Post-Hoc Results from Phase IIb Studies of Anifrolumab and Sifalimumab
Abstract Number: 2819

Association of Socioeconomic Status with Osteoarthritis-Induced Disability Progression
Abstract Number: 1975

Association of the 16519 Polymorphism in Patients with Fibromyalgia. Case-Control Study
Abstract Number: 2148

Association of the Paraoxonase 1 Q192R Genetic Polymorphism with Disease Activity in Dermatomyositis
Abstract Number: 988

Association of Ultraviolet-B Radiation and Risk of SLE Among Women in the Nurses’ Health Studies
Abstract Number: 932

Association of Varus Knee Thrust during Walking to Worsening Knee Pain over Two Years
Abstract Number: 879

Association of Venous Thromboembolism with Spondyloarthopathies Among Hospitalized Patients – Data from National Inpatient Sample
Abstract Number: 1622

Associations Among Classification Criteria Items within Systemic Lupus Erythematosus
Abstract Number: 1146

Associations between Gout and Cancer in an Nhanes Cohort
Abstract Number: 1219

Associations between Muscle Mass and Function with Bone Microarchitecture and Bone Strength in Postmenopausal Women
Abstract Number: 688

Associations between Standard Serological Markers and Different Clinical Phenotypes in Systemic Lupus Erythematosus
Abstract Number: 1271

Associations between Systemic Lupus Susceptibility (SLE) Loci and Anti-Phospholipid Antibody (aPL) Positivity in Childhood-Onset SLE (cSLE)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].